-
-
-
-
-
-
-
Sanofi (SNY) Tops Q1 EPS by 9c
-
-
-
-
-
-
-
Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
-
-
-
-
-
-
-
Press release: Q3: continued sales and earnings progress
-
-
-
-
-
-
-
M. Stanley cuts Novo Nordisk to Underweight on ’tough path ahead’, shares slip
-
-
-
-
-
-
-
Sanofi to acquire Blueprint Medicines, $129 per share
-
-
-
-
-
-
-
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
-
-
-
-
-
-
-
Expect the beat-and-raise path to continue for this European pharma name
-
1,198,511 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

